Read + Share
Goldstein LJ, Perez RP, Yardley D, Han LK, et al. Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin
in operable HER-2-negative breast cancer. Breast Cancer Res 2020;22:52.
PMID: 32434589
|
 |
|
Goldstein LJ, Perez RP, Yardley D, Han LK, et al. Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin
in operable HER-2-negative breast cancer. Breast Cancer Res 2020;22:52.
PMID: 32434589
|
|
|
|